InnovAge Holding Corp(INNV) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.02 | Insider Own | 84.4% | Shs Outstand | 136.0M | Perf Week | 0.19% |
| Market Cap | 1.47B | Forward P/E | 21.98 | EPS next Y | 15.29% | Insider Trans | - | Shs Float | 21.3M | Perf Month | 1.13% |
| Enterprise Value | 1.45B | PEG | - | EPS next Q | 0.08 | Inst Own | 13.56% | Short Float | 4.82% | Perf Quarter | 18.22% |
| Income | -0.00B | P/S | 1.48 | EPS this Y | 2225% | Inst Trans | 2% | Short Ratio | 3.18 | Perf Half Y | 28.37% |
| Sales | 0.99B | P/B | 6.22 | EPS next 5Y | - | ROA | -0.44% | Short Interest | 1.03M | Perf YTD | 107.51% |
| Book/sh | 1.73 | P/C | 10.4 | EPS past 3/5Y | 60.35% 43.49% | ROE | -1.08% | 52W High | -14.79% ($12.64) | Perf Year | 136.7% |
| Cash/sh | 1.04 | P/FCF | 29.15 | Sales past 3/5Y | 12.88% 9.19% | ROIC | -0.82% | 52W Low | 173.7% ($3.93) | Perf 3Y | 58.62% |
| Dividend Est. | - | EV/EBITDA | 16.57 | EPS Y/Y TTM | 91.65% | Gross Margin | 20.88% | Volatility(W/M) | 7.09% 5% | Perf 5Y | -23.35% |
| Dividend TTM | - | EV/Sales | 1.46 | Sales Y/Y TTM | 15.93% | Oper. Margin | 6.7% | ATR (14) | 0.6 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.05 | EPS Q/Q | 1141.38% | Profit Margin | -0.26% | RSI (14) | 48.57 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.05 | Sales Q/Q | 18.31% | SMA20 | -0.69% ($10.84) | Beta | 0.13 | Target Price | $14 |
| Payout | - | Debt/Eq | 0.37 | Earnings | 2026/9/8 | SMA50 | -3.26% ($11.13) | Rel Volume | 0.66 | Prev Close | $10.75 |
| Employees | 2500 | LT Debt/Eq | 0.31 | EPS/Sales Surpr. | -19.68% 9.91% | SMA200 | 28.36% ($8.39) | Avg Volume(3M) | 0.32M | Price | $10.77 |
| IPO | 2021/3/4 | Option/Short | Yes/Yes | Trades | 3139 | Volume | 211,221 | Change | 0.19% |
Company
INNV is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏥 InnovAge Holding Corp. (INNV) is a healthcare company that operates the Program of All-Inclusive Care for the Elderly (PACE), a U.S. integrated care program for seniors. It provides medical, long-term care, and daily living support under one roof for elderly and vulnerable individuals who qualify for both Medicare and Medicaid, and has established itself as one of the largest for-profit PACE operators in the United States.
Over the past 1 year, on the higher side
15% below its 1-year high.
INNV has weak earning power
6.7% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +2225.0% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +58.6% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 13.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
FDLS 0.01%
JSML 0.00%
FSCC 0.00%
FEAC 0.00%
BUYO 0.00%It ranks #4 in the industry
Based on market cap of $1B.
INNV $1B PER -
HCA $92B PER 14.3
THC $21B PER 10.2
FMS $12B PER 11.8
FAQ
What kind of company is INNV?
INNV belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of INNV?
The market cap of INNV is approximately $1.5B, ranking 2,345 within its sector.
What is the 52-week high and low for INNV?
INNV has recorded a 52-week high of $12.64 and a low of $3.93.
